Centro de Imagem Diagnósticos S.A. (AALR3.SA)
BRL 5.11
(-0.97%)
BRL 5.11
(-0.97%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 154.72 Million BRL | 52.03% |
| 2022 | 49.75 Million BRL | -72.65% |
| 2021 | 206.49 Million BRL | 1202.77% |
| 2020 | 98.33 Million BRL | -93.49% |
| 2019 | 237.97 Million BRL | 17.85% |
| 2018 | 204.34 Million BRL | 34.76% |
| 2017 | 134.63 Million BRL | -35.46% |
| 2016 | 146.21 Million BRL | 229.28% |
| 2015 | 89.95 Million BRL | 5.59% |
| 2014 | 66.37 Million BRL | 17.96% |
| 2013 | 56.26 Million BRL | 23.63% |
| 2012 | 45.51 Million BRL | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 69.55 Million BRL | 192.89% |
| 2024 Q1 | 35.09 Million BRL | 187.17% |
| 2023 FY | - BRL | 52.03% |
| 2023 Q1 | 51.03 Million BRL | 328.5% |
| 2023 Q2 | 45.99 Million BRL | -9.87% |
| 2023 Q3 | 32.5 Million BRL | -29.32% |
| 2023 Q4 | -31.87 Million BRL | -198.05% |
| 2022 FY | - BRL | -72.65% |
| 2022 Q4 | -22.33 Million BRL | -5582.7% |
| 2022 Q3 | -393 Thousand BRL | -100.61% |
| 2022 Q1 | 13.46 Million BRL | 45.94% |
| 2022 Q2 | 64.14 Million BRL | 376.28% |
| 2021 FY | - BRL | 1202.77% |
| 2021 Q1 | 60.06 Million BRL | -13.51% |
| 2021 Q4 | 9.22 Million BRL | -86.33% |
| 2021 Q2 | 63.88 Million BRL | 6.36% |
| 2021 Q3 | 67.48 Million BRL | 5.64% |
| 2020 Q1 | -31.06 Million BRL | -149.99% |
| 2020 FY | - BRL | -93.49% |
| 2020 Q4 | 69.44 Million BRL | 140.71% |
| 2020 Q3 | 28.85 Million BRL | 155.67% |
| 2020 Q2 | -51.82 Million BRL | -66.86% |
| 2019 Q4 | 62.13 Million BRL | 22.63% |
| 2019 Q2 | 64.98 Million BRL | 10.82% |
| 2019 FY | - BRL | 17.85% |
| 2019 Q1 | 58.63 Million BRL | 8.9% |
| 2019 Q3 | 50.67 Million BRL | -22.03% |
| 2018 Q4 | 53.84 Million BRL | -0.9% |
| 2018 FY | - BRL | 34.76% |
| 2018 Q1 | 50.1 Million BRL | 754.85% |
| 2018 Q2 | 43.96 Million BRL | -12.27% |
| 2018 Q3 | 54.33 Million BRL | 23.6% |
| 2017 Q3 | 59.79 Million BRL | 41.48% |
| 2017 Q1 | 54.95 Million BRL | 60.85% |
| 2017 FY | - BRL | -35.46% |
| 2017 Q4 | -7.65 Million BRL | -112.8% |
| 2017 Q2 | 42.25 Million BRL | -23.1% |
| 2016 Q1 | 89.21 Million BRL | 138.03% |
| 2016 Q2 | 62.98 Million BRL | -29.41% |
| 2016 FY | - BRL | 229.28% |
| 2016 Q4 | 34.16 Million BRL | -23.29% |
| 2016 Q3 | 44.53 Million BRL | -29.29% |
| 2015 Q3 | 37.72 Million BRL | -6.63% |
| 2015 Q1 | 28.82 Million BRL | 0.0% |
| 2015 FY | - BRL | 5.59% |
| 2015 Q4 | 37.48 Million BRL | -0.64% |
| 2015 Q2 | 40.4 Million BRL | 40.15% |
| 2014 FY | - BRL | 17.96% |
| 2013 FY | - BRL | 23.63% |
| 2012 FY | - BRL | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Diagnósticos da América S.A. | 2.2 Billion BRL | 92.993% |
| Fleury S.A. | 1.7 Billion BRL | 90.904% |